Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Breast Cancer

Kevin Kalinsky

MD

🏢Emory Winship Cancer Institute🌐USA

Director, Glenn Family Breast Center

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Kevin Kalinsky is a breast oncologist who has been a major investigator in sacituzumab govitecan trials including ASCENT and TROPiCS-02. His clinical and translational work focuses on novel systemic therapies for metastatic breast cancer including TROP2-directed ADCs in the HR-positive and TNBC setting. He is an active contributor to SWOG breast cancer research.

Share:

🧪Research Fields 研究领域

sacituzumab govitecan ASCENT
TROP2 HR+ BC TROPiCS-02
TNBC treatment
CDK4/6 inhibitors
breast cancer novel therapeutics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kevin Kalinsky 的研究动态

Follow Kevin Kalinsky's research updates

留下邮箱,当我们发布与 Kevin Kalinsky(Emory Winship Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment